Mukka Proteins Analyst Review May 2026

This Mukka Proteins analyst review for May 2026 covers all critical data investors need for MUKKA at Rs 23.14. Mukka Proteins is a fish meal and fish oil processor. This Mukka Proteins analyst review analyses technical levels, business fundamentals, valuation, and key risks for MUKKA through FY27.

Click Here – Get Free Investment Predictions

Mukka Proteins Analyst Review: Company Snapshot May 2026

Mukka Proteins processes fish meal and fish oil from marine fish for aquaculture feed and animal nutrition markets. The table below summarises key metrics for this Mukka Proteins analyst review.

Parameter	Value
NSE Ticker	MUKKA
Sector	FMCG – Fish Meal and Fish Oil
CMP (May 2026)	Rs 23.14
52 Week High	Rs 27.76
52 Week Low	Rs 18.52
Market Cap	Rs 1200 Crore
Trailing P/E	22x
Analyst Consensus Target	Rs 28.93
Bull Case Target	Rs 35.87
Bear Case Target	Rs 19.67

Analyst Insight: Mukka Proteins Analyst Review for FY27

Associate Director Kunal Singla suggests watching Mukka Proteins closely in May 2026. At Rs 23.14, Kunal Singla flags FMCG – Fish Meal and Fish Oil sector dynamics as the key driver for MUKKA’s price action. Support is near Rs 18.89 and resistance near Rs 24.53. Kunal Singla’s perspective in this Mukka Proteins analyst review is not a buy recommendation.

Technical Analysis in This Mukka Proteins Analyst Review

This Mukka Proteins analyst review places MUKKA at Rs 23.14 within its 52-week band of Rs 18.52 to Rs 27.76. The 14-day RSI, MACD signal, and volume profile are key technical inputs when evaluating MUKKA.

The Mukka Proteins analyst review identifies support in the Rs 18.89 to Rs 21.98 range and resistance in the Rs 24.53 to Rs 26.04 zone. A sustained close above Rs 24.53 could signal momentum toward the analyst consensus target of Rs 28.93.

Screen the best stocks on the Univest Screener.

Support and Resistance in This Mukka Proteins Analyst Review

• Support Zone: Rs 18.89 to Rs 21.98 – this Mukka Proteins analyst review identifies this as a potential accumulation signal for MUKKA.
• Resistance Zone: Rs 24.53 to Rs 26.04 – the Mukka Proteins analyst review flags a close above Rs 24.53 as a positive signal for MUKKA.
• Consensus Target: Rs 28.93 is the base-case target in this Mukka Proteins analyst review.

Business Segments in This Mukka Proteins Analyst Review

Fish Meal Manufacturing

This primary segment drives revenue and margin for Mukka Proteins, supporting the earnings trajectory toward Rs 28.93 in this Mukka Proteins analyst review.

Fish Oil Processing

This segment adds meaningful scale to Mukka Proteins’s model and is a key EPS contributor through FY27 as identified in this Mukka Proteins analyst review.

Aquaculture and Poultry Feed Supply

This growth frontier is a potential re-rating catalyst for MUKKA and a key element of this Mukka Proteins analyst review.

Valuation: Mukka Proteins Analyst Review Bull Bear Base Case

At Rs 23.14 and P/E of 22x, this Mukka Proteins analyst review sets three scenarios: bull case Rs 35.87, base case Rs 28.93, and bear case Rs 19.67.

Scenario	Target Price	Key Condition
Bull Case	Rs 35.87	Strong FY27 delivery and FMCG – Fish Meal and Fish Oil re-rating
Base Case	Rs 28.93	Moderate growth per analyst consensus in this Mukka Proteins analyst review
Bear Case	Rs 19.67	Earnings miss or macro headwinds for MUKKA

FY27 Outlook in This Mukka Proteins Analyst Review

This Mukka Proteins analyst review for FY27 is constructive provided MUKKA delivers on earnings expectations. Q1 FY27 results will be the first checkpoint. Investors should monitor FMCG – Fish Meal and Fish Oil indicators, RBI policy, and FII flow trends.

Key Risks in This Mukka Proteins Analyst Review

This Mukka Proteins analyst review identifies four key risks for MUKKA: macro slowdown, input cost pressure, FII selling, and Q1 FY27 earnings disappointment.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Mukka Proteins Analyst Review Verdict May 2026

This Mukka Proteins analyst review concludes that MUKKA at Rs 23.14 presents a defined risk-reward with consensus target Rs 28.93. The 52-week range of Rs 18.52 to Rs 27.76 provides further context. Use this Mukka Proteins analyst review as a research reference and consult a SEBI-registered advisor before investing in MUKKA.

FAQs: Mukka Proteins Analyst Review 2026

What is the analyst target for Mukka Proteins in 2026?

The Mukka Proteins analyst review consensus target is Rs 28.93, bull case Rs 35.87, bear case Rs 19.67.

Is Mukka Proteins a good buy at Rs 23.14?

At Rs 23.14 with PE 22x and target Rs 28.93, this Mukka Proteins analyst review is constructive for 12-month investors. Consult a SEBI-registered advisor before acting on this Mukka Proteins analyst review.

What is the 52-week high and low of Mukka Proteins?

52-week high is Rs 27.76 and 52-week low is Rs 18.52. This Mukka Proteins analyst review contextualises MUKKA at Rs 23.14 within this range.

What are the key risks for Mukka Proteins?

Key risks in this Mukka Proteins analyst review: macro slowdown, input cost pressure, FII selling, and competitive pressure in the FMCG – Fish Meal and Fish Oil sector.

Where can I track live data for Mukka Proteins?

Track Mukka Proteins’s live price on the Univest Screener to complement this Mukka Proteins analyst review with real-time data.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.